This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

Switching Adult Patients with Active Psoriatic Arthritis from Other Biologics to TREMFYA

Last Updated: 01/04/2025

SUMMARY  

  • The company cannot recommend any practices, procedures, or usage that deviate from the approved labeling.
  • Please refer to the local labeling for information on the recommended dosing and administration of TREMFYA in adult patients with active psoriatic arthritis.

Literature Search

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, DERWENT® (and/or other resources, including internal/external databases) conducted on 31 July 2024 did not identify any relevant citations pertaining to this topic.